The Pfizer New Haven Clinical Research Unit is conducting a clinical trial of a study drug for certain types of cancer and solid tumors. This study will look at the amount of the study drug in the body after a single oral dose when taken with an additional medication, with or without food.
The study drug is being evaluated for the treatment of specific cancers and solid tumors, including breast and prostate cancer. Millions of people are diagnosed with these cancers every year. Affected patients are in need of effective and safe treatments, and healthy volunteers are an important part of developing these medicines.
Read more about this study below and see if you can make a difference as a healthy volunteer.
Who may participate
By volunteering in clinical research, you can make a difference.
This study is seeking healthy adult volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements:
- Willing to take a study drug
- Willing and able to come to our facility in New Haven, CT*
- Able to comply with all study procedures
*participants may be eligible to receive a bonus for travel, ask our staff for details
There are other requirements for participation in this study. The study staff will explain these to you during the screening process.
Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus.
Condition
Healthy
Age
18-65 years
Sex
All sexes
Referral bonus
Up to $100
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
If this study may be a fit for you, you’ll be invited to a screening visit at our facility in New Haven, CT. If you qualify for the study, there may be a period of up to 28 days before dosing.
If you choose to participate, you will stay at our facility for 13 overnights. On the morning after admission, you will receive a single dose of the study drug with or without food. About 3 days after this, starting in the evening and then each morning for 6 days, you will receive a single oral dose of an additional medication, for up to 7 total doses. About 4 hours after the last dose of this medication, you will also receive another oral dose of the study drug with or without food.
Throughout the study, staff will closely monitor your health status and collect data, such as how you feel and the levels of the study drug in your blood.
*Some participants may be required to return for a follow-up visit and will receive an additional $150
Required overnight stays
13
Long-term follow up
1 phone-call*
How long is this study?
About 39 days
Compensation
Up to $4,585* upon completion of the study
All of the study procedures will be clearly explained to you during screening and can be viewed by downloading the informed consent form.
The PCRU Loyalty Program has arrived!
Our new Loyalty Program offers unique tiered gifts for new and returning participants.
Interested in participating?
Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you. Please note: volunteers completing this form must be able to read and speak English at an 8th grade level.
You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.
For Japanese language assistance only, please call 1-833-711-9984. We apologize, our representatives cannot take calls in languages other than English or Japanese at this time.
The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.